Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Myeloid 1

Conditions

Pleural Effusion, Malignant 1Myeloproliferative Disorder, Chronic, with Eosinophilia 1

Interventions

Specimen Handling 3Biopsy 3venetoclax 2selinexor 2luspatercept 2Tacrolimus 2Lymphatic Irradiation 2Imatinib Mesylate 2Busulfan 2Azacitidine 2trametinib 1tagraxofusp 1peginterferon alfa-2b 1olutasidenib 1nilotinib 1flumatinib 1fludarabine phosphate 1fludarabine 1decitabine and cedazuridine drug combination 1dabrafenib 1Tyrosine Kinase Inhibitors 1Thiotepa 1Spectroscopy, Near-Infrared 1Sirolimus 1Single-Cell Gene Expression Analysis 1Resistance Training 1Receptors, Antigen, T-Cell 1Quality of Life 1Pleurodesis 1Phlebotomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Pleurodesis × Myeloid × Clear all
NCT06742099 2024-12-19

The Outcome of Inserting Intercostal Tube or Pleurodesis for Malignant Pleural Effusion

Assiut University

Phase EARLY_PHASE1 Not yet recruiting
20 enrolled
MyeloidThoracic

Myeloproliferative Disorder, Chronic, with Eosinophilia, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡